188 related articles for article (PubMed ID: 35409102)
1. Pyruvate Dehydrogenase Kinase Inhibition by Dichloroacetate in Melanoma Cells Unveils Metabolic Vulnerabilities.
Tiersma JF; Evers B; Bakker BM; Jalving M; de Jong S
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409102
[TBL] [Abstract][Full Text] [Related]
2. Suppression of Pyruvate Dehydrogenase Kinase by Dichloroacetate in Cancer and Skeletal Muscle Cells Is Isoform Specific and Partially Independent of HIF-1α.
Škorja Milić N; Dolinar K; Miš K; Matkovič U; Bizjak M; Pavlin M; Podbregar M; Pirkmajer S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445316
[TBL] [Abstract][Full Text] [Related]
3. Pyruvate dehydrogenase kinase expression and metabolic changes following dichloroacetate exposure in anoxic human colorectal cancer cells.
Ho N; Coomber BL
Exp Cell Res; 2015 Feb; 331(1):73-81. PubMed ID: 25536473
[TBL] [Abstract][Full Text] [Related]
4. Dichloroacetate and Pyruvate Metabolism: Pyruvate Dehydrogenase Kinases as Targets Worth Investigating for Effective Therapy of Toxoplasmosis.
Ferrarini MG; Nisimura LM; Girard RMBM; Alencar MB; Fragoso MSI; Araújo-Silva CA; Veiga AA; Abud APR; Nardelli SC; Vommaro RC; Silber AM; France-Sagot M; Ávila AR
mSphere; 2021 Jan; 6(1):. PubMed ID: 33408226
[TBL] [Abstract][Full Text] [Related]
5. Dichloroacetate Radiosensitizes Hypoxic Breast Cancer Cells.
de Mey S; Dufait I; Jiang H; Corbet C; Wang H; Van De Gucht M; Kerkhove L; Law KL; Vandenplas H; Gevaert T; Feron O; De Ridder M
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33316932
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy.
Pópulo H; Caldas R; Lopes JM; Pardal J; Máximo V; Soares P
Expert Opin Ther Targets; 2015 Jun; 19(6):733-45. PubMed ID: 25976231
[TBL] [Abstract][Full Text] [Related]
7. Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target.
Hur H; Xuan Y; Kim YB; Lee G; Shim W; Yun J; Ham IH; Han SU
Int J Oncol; 2013 Jan; 42(1):44-54. PubMed ID: 23135628
[TBL] [Abstract][Full Text] [Related]
8. Reprogramming Energy Metabolism with Synthesized PDK Inhibitors Based on Dichloroacetate Derivatives and Targeted Delivery Systems for Enhanced Cancer Therapy.
She W; Liu T; Li H; Wang Z; Guo Z; Liu Y; Liu Y
J Med Chem; 2023 Nov; 66(21):14683-14699. PubMed ID: 37688544
[TBL] [Abstract][Full Text] [Related]
9. Pivotal role of the C-terminal DW-motif in mediating inhibition of pyruvate dehydrogenase kinase 2 by dichloroacetate.
Li J; Kato M; Chuang DT
J Biol Chem; 2009 Dec; 284(49):34458-67. PubMed ID: 19833728
[TBL] [Abstract][Full Text] [Related]
10. ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells.
Cesi G; Walbrecq G; Zimmer A; Kreis S; Haan C
Mol Cancer; 2017 Jun; 16(1):102. PubMed ID: 28595656
[TBL] [Abstract][Full Text] [Related]
11. High-dose vitamin B1 reduces proliferation in cancer cell lines analogous to dichloroacetate.
Hanberry BS; Berger R; Zastre JA
Cancer Chemother Pharmacol; 2014 Mar; 73(3):585-94. PubMed ID: 24452394
[TBL] [Abstract][Full Text] [Related]
12. Impact of Sodium Dichloroacetate Alone and in Combination Therapies on Lung Tumor Growth and Metastasis.
Al-Azawi A; Sulaiman S; Arafat K; Yasin J; Nemmar A; Attoub S
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830434
[TBL] [Abstract][Full Text] [Related]
13. Sensitization of metformin-cytotoxicity by dichloroacetate via reprogramming glucose metabolism in cancer cells.
Choi YW; Lim IK
Cancer Lett; 2014 May; 346(2):300-8. PubMed ID: 24480191
[TBL] [Abstract][Full Text] [Related]
14. Acidosis-induced metabolic reprogramming in tumor cells enhances the anti-proliferative activity of the PDK inhibitor dichloroacetate.
Schoonjans CA; Joudiou N; Brusa D; Corbet C; Feron O; Gallez B
Cancer Lett; 2020 Feb; 470():18-28. PubMed ID: 31812695
[TBL] [Abstract][Full Text] [Related]
15. Liquid Chromatography-Tandem Mass Spectrometry Method Revealed that Lung Cancer Cells Exhibited Distinct Metabolite Profiles upon the Treatment with Different Pyruvate Dehydrogenase Kinase Inhibitors.
Zhang W; Hu X; Zhou W; Tam KY
J Proteome Res; 2018 Sep; 17(9):3012-3021. PubMed ID: 30028142
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Sodium Dichloroacetate on Mitochondrial Dysfunction and Neuronal Death Following Hypoglycemia-Induced Injury.
Kho AR; Choi BY; Lee SH; Hong DK; Jeong JH; Kang BS; Kang DH; Park KH; Park JB; Suh SW
Cells; 2019 May; 8(5):. PubMed ID: 31052436
[TBL] [Abstract][Full Text] [Related]
17. Activation of Pyruvate Dehydrogenase by Sodium Dichloroacetate Shifts Metabolic Consumption from Amino Acids to Glucose in IPEC-J2 Cells and Intestinal Bacteria in Pigs.
An R; Tang Z; Li Y; Li T; Xu Q; Zhen J; Huang F; Yang J; Chen C; Wu Z; Li M; Sun J; Zhang X; Chen J; Wu L; Zhao S; Qingyan J; Zhu W; Yin Y; Sun Z
J Agric Food Chem; 2018 Apr; 66(15):3793-3800. PubMed ID: 29471628
[TBL] [Abstract][Full Text] [Related]
18. Dichloroacetate induces regulatory T-cell differentiation and suppresses Th17-cell differentiation by pyruvate dehydrogenase kinase-independent mechanism.
Makita N; Ishiguro J; Suzuki K; Nara F
J Pharm Pharmacol; 2017 Jan; 69(1):43-51. PubMed ID: 27757958
[TBL] [Abstract][Full Text] [Related]
19. Pyruvate Dehydrogenase Kinase Inhibitor Dichloroacetate Improves Host Control of
van Doorn CLR; Schouten GK; van Veen S; Walburg KV; Esselink JJ; Heemskerk MT; Vrieling F; Ottenhoff THM
Front Immunol; 2021; 12():739938. PubMed ID: 34552598
[TBL] [Abstract][Full Text] [Related]
20. Dichloroacetate, a pyruvate dehydrogenase kinase inhibitor, ameliorates type 2 diabetes via reduced gluconeogenesis.
Katayama Y; Kawata Y; Moritoh Y; Watanabe M
Heliyon; 2022 Feb; 8(2):e08889. PubMed ID: 35169648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
